These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11377072)

  • 1. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
    Al-Omari MM; Abdelah MK; Badwan AA; Jaber AM
    J Pharm Biomed Anal; 2001 Jul; 25(5-6):893-902. PubMed ID: 11377072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM; dos Santos LD; Lima EM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of stability of enalapril maleate in solid phase.
    Stanisz B
    J Pharm Biomed Anal; 2003 Feb; 31(2):375-80. PubMed ID: 12609677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B
    Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new impurities of enalapril maleate on oxidation in the presence of magnesium monoperoxyphthalate.
    Toporisic R; Mlakar A; Hvala J; Prislan I; Zupancic-Kralj L
    J Pharm Biomed Anal; 2010 Jun; 52(2):294-9. PubMed ID: 20122808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
    Eyjolfsson R
    Pharmazie; 2002 May; 57(5):347-8. PubMed ID: 12061263
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of stearic acid on enalapril stability and dissolution from multiparticulate solid dosage forms.
    Cunha TA; Serpa RC; de Oliveira AP; Nasser LN; de Freitas LA; Taveira SF; Diniz DG; Lima EM; Marreto RN
    AAPS PharmSciTech; 2013 Sep; 14(3):1150-7. PubMed ID: 23897034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fluorescent assay for enalapril maleate.
    de los A Oliva M; Sombra LL; Olsina RA; Masi AN
    J Fluoresc; 2005 Sep; 15(5):723-8. PubMed ID: 16341789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of commonly used excipients on the chemical degradation of enalapril maleate in its solid state: The role of condensed water.
    Bout MR; Vromans H
    Eur J Pharm Sci; 2022 Apr; 171():106121. PubMed ID: 35007714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
    Casas M; Álvarez J; Lucero MJ
    Pharm Dev Technol; 2015 May; 20(3):271-8. PubMed ID: 24279906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of enalapril maleate in three extemporaneously prepared oral liquids.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1998 Jun; 55(11):1155-7. PubMed ID: 9626379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
    Vehovec T; Gartner A; Planinšek O; Obreza A
    Acta Pharm; 2012 Dec; 62(4):515-28. PubMed ID: 23333887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of enalapril maleate chemical stability by high shear melting granulation.
    de Oliveira APM; Cunha TA; Serpa RC; Taveira SF; Lima EM; Almeida Diniz DG; de Freitas LAP; Marreto RN
    Pharm Dev Technol; 2015 Dec; 20(8):1002-1008. PubMed ID: 25231642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.